MedPath

National Heart, Lung, and Blood Institute

National Heart, Lung, and Blood Institute logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Comparison of Hematocrit Levels in Infant Heart Surgery

Phase 3
Completed
Conditions
Heart Defects, Congenital
Transposition of Great Vessels
Heart Diseases
Cardiovascular Diseases
First Posted Date
2000-08-22
Last Posted Date
2016-07-29
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
120
Registration Number
NCT00006183
Locations
🇺🇸

Children's Hospital, Boston, Massachusetts, United States

Stroke Prevention in Sickle Cell Anemia (STOP 2)

Phase 3
Completed
Conditions
Cerebrovascular Accident
Blood Disease
Anemia, Sickle Cell
First Posted Date
2000-08-22
Last Posted Date
2016-02-18
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00006182

Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic Anemia

Phase 2
Completed
Conditions
Aplastic Anemia
First Posted Date
2000-07-07
Last Posted Date
2008-03-04
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
130
Registration Number
NCT00005935
Locations
🇺🇸

National Heart, Lung and Blood Institute (NHLBI), Bethesda, Maryland, United States

Collection of Liver Tissue for Virologic Studies

Completed
Conditions
Virus Disease
First Posted Date
2000-07-07
Last Posted Date
2008-03-04
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
50
Registration Number
NCT00005936
Locations
🇺🇸

National Heart, Lung and Blood Institute (NHLBI), Bethesda, Maryland, United States

Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation

Phase 2
Completed
Conditions
Atherosclerosis
Coronary Disease
Vasculitis
First Posted Date
2000-06-29
Last Posted Date
2008-03-04
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
25
Registration Number
NCT00005928
Locations
🇺🇸

National Heart, Lung and Blood Institute (NHLBI), Bethesda, Maryland, United States

Treatment With Octreotide in Patients With Lymphangioleiomyomatosis

Phase 2
Completed
Conditions
Lymphangioleiomyomatosis
Lymphangiomyomas
Pleural Effusions
Ascites
Interventions
First Posted Date
2000-06-12
Last Posted Date
2010-04-30
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
4
Registration Number
NCT00005906
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Genetic and Epidemiologic Studies of Premature Coronary Artery Disease - SCOR in Arteriosclerosis

Completed
Conditions
Coronary Disease
Cardiovascular Diseases
Heart Diseases
First Posted Date
2000-05-26
Last Posted Date
2016-09-28
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00005324

Mechanisms of Low Levels of Apolipoprotein B

Completed
Conditions
Heart Diseases
Cardiovascular Diseases
Hypobetalipoproteinemia
First Posted Date
2000-05-26
Last Posted Date
2016-07-29
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00005565

Hypertension in Blacks of West African Origin

Completed
Conditions
Cardiovascular Diseases
Heart Diseases
Hypertension
Obesity
First Posted Date
2000-05-26
Last Posted Date
2016-07-29
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00005340

Genetics of Hypertension in Blacks

Completed
Conditions
Cardiovascular Diseases
Heart Diseases
Hypertension
First Posted Date
2000-05-26
Last Posted Date
2016-07-12
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00005387
© Copyright 2025. All Rights Reserved by MedPath